l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Trimethylamine N-Oxide From Gut Microbiota

Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect Meat metabolizing bacteria in atherosclerosis Nature Medicine Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target

SKU: 9490117302 · From hgidocs.co